Caliber Wealth Management LLC KS Sells 1,295 Shares of HCA Healthcare, Inc. $HCA

Caliber Wealth Management LLC KS reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 15.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,885 shares of the company’s stock after selling 1,295 shares during the quarter. Caliber Wealth Management LLC KS’s holdings in HCA Healthcare were worth $2,934,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Norges Bank acquired a new position in shares of HCA Healthcare during the second quarter valued at about $1,152,408,000. Pacer Advisors Inc. boosted its stake in HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after purchasing an additional 896,437 shares during the last quarter. Viking Global Investors LP lifted its holdings in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in HCA Healthcare in the 2nd quarter valued at $109,337,000. Finally, HRT Financial LP purchased a new position in HCA Healthcare during the 2nd quarter worth $81,596,000. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several analyst reports. Raymond James Financial set a $525.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Argus upped their price objective on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research note on Friday. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Truist Financial boosted their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Finally, Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Sixteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $521.55.

HCA Healthcare Trading Down 2.3%

Shares of HCA opened at $501.89 on Friday. The stock has a 50-day moving average price of $479.97 and a 200-day moving average price of $442.72. The company has a market cap of $114.53 billion, a PE ratio of 17.68, a price-to-earnings-growth ratio of 1.54 and a beta of 1.36. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $527.55.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the prior year, the firm earned $6.22 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is 10.99%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.